A novel nitric oxide-releasing heparin conjugate successfully combines antiplatelet and anticoagulant activities in vitro.
No takes yet. Share an insight, caveat, or question.
Supports dual antithrombotic development; leaves open in vivo efficacy, safety, and clinical translation.
Suchyta et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: